<p>Phreesia（纽约证券交易所代码：PHR - 获取免费报告）在周四发布给投资者的报告中，被巴克莱的研究分析师将评级从 “强力买入” 下调至 “持有”，Zacks.com 报道。</p>
<ul>
<li>Phreesia 在第一季度触底：反弹在即，时机不确定</li>
</ul>
<p>其他分析师最近也发布了关于该股票的研究报告。瑞穗证券将 Phreesia 的目标价格从 22.00 美元下调至 19.00 美元，并在 3 月 24 日的研究报告中给予该股票 “跑赢大盘” 的评级。DA Davidson 将 Phreesia 的目标价格从 35.00 美元下调至 30.00 美元，并在 1 月 23 日的研究报告中给予该公司 “买入” 评级。Citizens Jmp 在 4 月 1 日的研究报告中重申了 Phreesia 的 “市场表现” 评级。花旗集团在 3 月 31 日的研究报告中重申了 “中性” 评级，并将 Phreesia 的目标价格下调至 10.00 美元（低于 25.00 美元）。最后，BMO 资本市场在 3 月 31 日的研究报告中将 Phreesia 的目标价格从 32.00 美元下调至 14.00 美元，并给予该公司 “跑赢大盘” 评级。共有 11 位分析师给予该股票 “买入” 评级，7 位给予 “持有” 评级，1 位给予 “卖出” 评级。根据 MarketBeat.com 的数据，Phreesia 的共识评级为 “适度买入”，共识目标价格为 20.00 美元。</p>
<p><strong>阅读我们关于 PHR 的最新研究报告</strong></p>
<h2>Phreesia 股价上涨 0.1%</h2>
<ul>
<li>Waystar 还能抵御日益激烈的竞争吗？</li>
</ul>
<p>纽约证券交易所：PHR 周四开盘价为 8.78 美元。该公司的 50 日简单移动平均线为 9.94 美元，200 日简单移动平均线为 14.53 美元。公司的债务与股本比率为 0.41，速动比率为 1.53，流动比率为 1.53。Phreesia 的年内最低价为 7.77 美元，年内最高价为 32.76 美元。该公司的市值为 5.3329 亿美元，市盈率为 292.57，贝塔值为 0.89。</p>
<p>Phreesia（纽约证券交易所代码：PHR - 获取免费报告）最近在 3 月 30 日发布了季度财报。该公司报告每股收益（EPS）为 0.02 美元，低于分析师的共识预期 0.07 美元，差距为 0.05 美元。Phreesia 的股本回报率为 3.23%，净利润率为 0.48%。该公司在本季度的收入为 1.2707 亿美元，而分析师预期为 1.2675 亿美元。在去年同期，该公司的每股收益为（0.11）美元。该公司的季度收入同比增长 15.9%。股票分析师预计 Phreesia 在当前财政年度将发布 0.28 美元的每股收益。</p>
<h2>内部活动</h2>
<ul>
<li>Phreesia 股票是医疗 IT 领域的投资</li>
</ul>
<p>在其他新闻中，内部人士 David Linetsky 在 4 月 10 日的交易中出售了 8,332 股该公司的股票。股票以平均价格 8.07 美元出售，总交易额为 67,239.24 美元。出售完成后，内部人士在公司中持有 224,056 股，价值 1,808,131.92 美元。此次交易代表其持股比例减少了 3.59%。该交易在向证券交易委员会的备案中披露，相关信息可在此链接查看。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，首席财务官 Balaji Gandhi 在 3 月 25 日的交易中出售了 3,829 股该股票。该股票以平均价格 11.26 美元出售，总交易额为 43,114.54 美元。交易完成后，首席财务官直接持有 146,740 股公司股票，价值约 1,652,292.40 美元。此次交易代表其持股比例减少了 2.54%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在上个季度出售了价值 461,983 美元的 50,493 股公司股票。目前，企业内部人士持有该股票的 5.50%。</p>
<h2>机构资金流入和流出</h2>
<p>几家对冲基金最近买入和卖出了该股票的股份。Raymond James Financial Inc.在第二季度将其在 Phreesia 的持股增加了 2.7%。Raymond James Financial Inc.现在拥有 14,049 股该公司的股票，价值 40 万美元，此前在该期间内又购买了 375 股。Alliancebernstein L.P.在第三季度将其在 Phreesia 的持股增加了 1.3%。Alliancebernstein L.P.现在拥有 62,712 股该公司的股票，价值 1,475,000 美元，此前在该期间内又购买了 812 股。Van ECK Associates Corp 在第四季度将其在 Phreesia 的持股增加了 78.7%。Van ECK Associates Corp 现在拥有 2,502 股该公司的股票，价值 42,000 美元，此前在该期间内又购买了 1,102 股。亚利桑那州退休系统在第三季度将其在 Phreesia 的持股增加了 8.1%。亚利桑那州退休系统现在拥有 17,608 股该公司的股票，价值 414,000 美元，此前在该期间内又购买了 1,313 股。最后，Federated Hermes Inc.在第三季度购买了 Phreesia 的新头寸，价值约 32,000 美元。对冲基金和其他机构投资者持有该公司 92.10% 的股票。</p>
<h2>Phreesia 新闻汇总</h2>
<p>以下是本周影响 Phreesia 的主要新闻故事：</p>
<ul>
<li>消极情绪：包括罗森律师事务所、Faruqi &amp; Faruqi、Pomerantz、Bragar Eagel &amp; Squire、Gross 律师事务所、Robbins LLP 和 Gainey McKenna &amp; Egleston 在内的多家律师事务所宣布或推广针对 Phreesia 的集体诉讼，指控其在 2025 年 5 月 8 日至 2026 年 3 月 30 日期间可能存在证券欺诈。文章标题</li>
<li>消极情绪：这些诉讼及相关投资者警报可能增加法律费用、管理层分心，并对之前的披露产生不确定性，这可能会影响投资者对该股票的情绪。文章标题</li>
<li>中性情绪：Phreesia 最新的季度业绩表现参差不齐：收入略高于预期，但每股收益未达到共识，这可能仍在影响投资者对公司基本面的看法。</li>
<li>中性情绪：尽管近期新闻流动频繁，分析师们之前总体上仍持建设性态度，给予多个买入/跑赢大盘评级，且中位目标价高于当前股价，表明仍然存在一些长期乐观情绪。</li>
</ul>
<h2>关于 Phreesia</h2>
<p>(获取免费报告)</p>
<p>Phreesia, Inc NYSE: PHR 是一家提供患者接收管理解决方案的公司，旨在简化医疗机构的前台工作流程。该公司的基于云的平台通过触摸屏自助服务机、平板电脑和移动设备数字化患者注册、预约安排、保险验证、同意文件和付款收集。通过替代纸质表格和手动流程，Phreesia 提高了数据准确性，减少了行政负担，并改善了患者体验。</p>
<p>Phreesia 成立于 2000 年，由 Chaim Indig 创办，总部位于马萨诸塞州伯灵顿，提供与电子病历（EMR）和实践管理系统集成的模块化软件套件。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Phreesia</li>
<li>Viking 股价创历史新高——基本面信号显示未来还有更多</li>
<li>Datavalut 获得关注：现在卖出的五个理由</li>
<li>TMC 股票：为什么这家未盈利的矿业公司值得关注</li>
<li>电网正在衰退——是时候购买其替代品了吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBIUg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBIUg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Phreesia 吗？</h2>
<p>在考虑 Phreesia 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Phreesia 并不在名单上。</p>
<p>虽然 Phreesia 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>巴克莱将 Phreesia（纽约证券交易所代码：PHR）的评级从 “强力买入” 下调至 “持有”。其他分析师也调整了他们的评级和目标价格，瑞穗将目标价格从 22 美元下调至 19 美元，DA Davidson 则从 35 美元下调至 30 美元。Phreesia 的股票共识评级为 “适度买入”，目标价格为 20 美元。该公司报告的季度每股收益为 0.02 美元，未达到预期，收入为 1.2707 亿美元，同比增长 15.9%</p>

<p>Phreesia (NYSE:PHR - Get Free Report) was downgraded by research analysts at Barclays from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a note issued to investors on Thursday,Zacks.com reports.</p>
<div class="lb-trans"><p>Phreesia（纽约证券交易所代码：PHR - 获取免费报告）在周四发布给投资者的报告中，被巴克莱的研究分析师将评级从 “强力买入” 下调至 “持有”，Zacks.com 报道。</p>
</div><ul>
<li>Phreesia Hits Bottom in Q1: Rebound Ahead, Timing Uncertain</li>
</ul>
<div class="lb-trans"><ul>
<li>Phreesia 在第一季度触底：反弹在即，时机不确定</li>
</ul>
</div><p>Other analysts also recently issued research reports about the stock. Mizuho dropped their target price on shares of Phreesia from $22.00 to $19.00 and set an &#34;outperform&#34; rating on the stock in a research report on Tuesday, March 24th. DA Davidson decreased their price objective on shares of Phreesia from $35.00 to $30.00 and set a &#34;buy&#34; rating for the company in a research note on Friday, January 23rd. Citizens Jmp reiterated a &#34;market perform&#34; rating on shares of Phreesia in a research note on Wednesday, April 1st. Citigroup reiterated a &#34;neutral&#34; rating and issued a $10.00 target price (down from $25.00) on shares of Phreesia in a research note on Tuesday, March 31st. Finally, BMO Capital Markets reduced their price objective on shares of Phreesia from $32.00 to $14.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, March 31st. Eleven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Phreesia has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $20.00.</p>
<div class="lb-trans"><p>其他分析师最近也发布了关于该股票的研究报告。瑞穗证券将 Phreesia 的目标价格从 22.00 美元下调至 19.00 美元，并在 3 月 24 日的研究报告中给予该股票 “跑赢大盘” 的评级。DA Davidson 将 Phreesia 的目标价格从 35.00 美元下调至 30.00 美元，并在 1 月 23 日的研究报告中给予该公司 “买入” 评级。Citizens Jmp 在 4 月 1 日的研究报告中重申了 Phreesia 的 “市场表现” 评级。花旗集团在 3 月 31 日的研究报告中重申了 “中性” 评级，并将 Phreesia 的目标价格下调至 10.00 美元（低于 25.00 美元）。最后，BMO 资本市场在 3 月 31 日的研究报告中将 Phreesia 的目标价格从 32.00 美元下调至 14.00 美元，并给予该公司 “跑赢大盘” 评级。共有 11 位分析师给予该股票 “买入” 评级，7 位给予 “持有” 评级，1 位给予 “卖出” 评级。根据 MarketBeat.com 的数据，Phreesia 的共识评级为 “适度买入”，共识目标价格为 20.00 美元。</p>
</div><p><strong>Read Our Latest Research Report on PHR</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 PHR 的最新研究报告</strong></p>
</div><h2>Phreesia Trading Up 0.1%</h2>
<div class="lb-trans"><h2>Phreesia 股价上涨 0.1%</h2>
</div><ul>
<li>Can Waystar Still Stand Up to Rising Competition?</li>
</ul>
<div class="lb-trans"><ul>
<li>Waystar 还能抵御日益激烈的竞争吗？</li>
</ul>
</div><p>NYSE:PHR opened at $8.78 on Thursday. The firm has a 50-day simple moving average of $9.94 and a 200-day simple moving average of $14.53. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.53 and a current ratio of 1.53. Phreesia has a one year low of $7.77 and a one year high of $32.76. The firm has a market cap of $533.29 million, a P/E ratio of 292.57 and a beta of 0.89.</p>
<div class="lb-trans"><p>纽约证券交易所：PHR 周四开盘价为 8.78 美元。该公司的 50 日简单移动平均线为 9.94 美元，200 日简单移动平均线为 14.53 美元。公司的债务与股本比率为 0.41，速动比率为 1.53，流动比率为 1.53。Phreesia 的年内最低价为 7.77 美元，年内最高价为 32.76 美元。该公司的市值为 5.3329 亿美元，市盈率为 292.57，贝塔值为 0.89。</p>
</div><p>Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Monday, March 30th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.07 by ($0.05). Phreesia had a return on equity of 3.23% and a net margin of 0.48%.The firm had revenue of $127.07 million during the quarter, compared to analysts' expectations of $126.75 million. During the same period in the previous year, the firm earned ($0.11) EPS. The firm's quarterly revenue was up 15.9% on a year-over-year basis. Equities analysts anticipate that Phreesia will post 0.28 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Phreesia（纽约证券交易所代码：PHR - 获取免费报告）最近在 3 月 30 日发布了季度财报。该公司报告每股收益（EPS）为 0.02 美元，低于分析师的共识预期 0.07 美元，差距为 0.05 美元。Phreesia 的股本回报率为 3.23%，净利润率为 0.48%。该公司在本季度的收入为 1.2707 亿美元，而分析师预期为 1.2675 亿美元。在去年同期，该公司的每股收益为（0.11）美元。该公司的季度收入同比增长 15.9%。股票分析师预计 Phreesia 在当前财政年度将发布 0.28 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><ul>
<li>Phreesia Stock is a Healthcare IT Play</li>
</ul>
<div class="lb-trans"><ul>
<li>Phreesia 股票是医疗 IT 领域的投资</li>
</ul>
</div><p>In other news, insider David Linetsky sold 8,332 shares of the firm's stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $8.07, for a total transaction of $67,239.24. Following the completion of the sale, the insider owned 224,056 shares in the company, valued at $1,808,131.92. This trade represents a 3.59% decrease in their position. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Balaji Gandhi sold 3,829 shares of the stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of $11.26, for a total transaction of $43,114.54. Following the transaction, the chief financial officer directly owned 146,740 shares of the company's stock, valued at approximately $1,652,292.40. This trade represents a 2.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 50,493 shares of company stock worth $461,983 over the last quarter. 5.50% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在其他新闻中，内部人士 David Linetsky 在 4 月 10 日的交易中出售了 8,332 股该公司的股票。股票以平均价格 8.07 美元出售，总交易额为 67,239.24 美元。出售完成后，内部人士在公司中持有 224,056 股，价值 1,808,131.92 美元。此次交易代表其持股比例减少了 3.59%。该交易在向证券交易委员会的备案中披露，相关信息可在此链接查看。该交易是在预先安排的 10b5-1 交易计划下执行的。出售是为了覆盖与股权奖励归属相关的税收扣缴义务。此外，首席财务官 Balaji Gandhi 在 3 月 25 日的交易中出售了 3,829 股该股票。该股票以平均价格 11.26 美元出售，总交易额为 43,114.54 美元。交易完成后，首席财务官直接持有 146,740 股公司股票，价值约 1,652,292.40 美元。此次交易代表其持股比例减少了 2.54%。有关此次出售的更多细节可在官方 SEC 披露中找到。内部人士在上个季度出售了价值 461,983 美元的 50,493 股公司股票。目前，企业内部人士持有该股票的 5.50%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Several hedge funds have recently bought and sold shares of the stock. Raymond James Financial Inc. boosted its stake in Phreesia by 2.7% during the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company's stock worth $400,000 after buying an additional 375 shares during the period. Alliancebernstein L.P. boosted its stake in Phreesia by 1.3% during the third quarter. Alliancebernstein L.P. now owns 62,712 shares of the company's stock worth $1,475,000 after buying an additional 812 shares during the period. Van ECK Associates Corp boosted its stake in Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company's stock worth $42,000 after buying an additional 1,102 shares during the period. Arizona State Retirement System boosted its stake in Phreesia by 8.1% during the third quarter. Arizona State Retirement System now owns 17,608 shares of the company's stock worth $414,000 after buying an additional 1,313 shares during the period. Finally, Federated Hermes Inc. purchased a new position in Phreesia during the third quarter worth about $32,000. Hedge funds and other institutional investors own 92.10% of the company's stock.</p>
<div class="lb-trans"><p>几家对冲基金最近买入和卖出了该股票的股份。Raymond James Financial Inc.在第二季度将其在 Phreesia 的持股增加了 2.7%。Raymond James Financial Inc.现在拥有 14,049 股该公司的股票，价值 40 万美元，此前在该期间内又购买了 375 股。Alliancebernstein L.P.在第三季度将其在 Phreesia 的持股增加了 1.3%。Alliancebernstein L.P.现在拥有 62,712 股该公司的股票，价值 1,475,000 美元，此前在该期间内又购买了 812 股。Van ECK Associates Corp 在第四季度将其在 Phreesia 的持股增加了 78.7%。Van ECK Associates Corp 现在拥有 2,502 股该公司的股票，价值 42,000 美元，此前在该期间内又购买了 1,102 股。亚利桑那州退休系统在第三季度将其在 Phreesia 的持股增加了 8.1%。亚利桑那州退休系统现在拥有 17,608 股该公司的股票，价值 414,000 美元，此前在该期间内又购买了 1,313 股。最后，Federated Hermes Inc.在第三季度购买了 Phreesia 的新头寸，价值约 32,000 美元。对冲基金和其他机构投资者持有该公司 92.10% 的股票。</p>
</div><h2>Phreesia News Roundup</h2>
<div class="lb-trans"><h2>Phreesia 新闻汇总</h2>
</div><p>Here are the key news stories impacting Phreesia this week:</p>
<div class="lb-trans"><p>以下是本周影响 Phreesia 的主要新闻故事：</p>
</div><ul>
<li>Negative Sentiment: Multiple law firms, including Rosen Law Firm, Faruqi &amp; Faruqi, Pomerantz, Bragar Eagel &amp; Squire, Gross Law Firm, Robbins LLP, and Gainey McKenna &amp; Egleston, announced or promoted class-action lawsuits against Phreesia, alleging potential securities fraud tied to the period from May 8, 2025 through March 30, 2026. Article Title</li>
<li>Negative Sentiment: The lawsuits and related investor alerts may increase legal costs, management distraction, and uncertainty around prior disclosures, which can weigh on investor sentiment toward the stock. Article Title</li>
<li>Neutral Sentiment: Phreesia’s latest quarterly results were mixed: revenue came in slightly above expectations, but EPS missed consensus, which may still be influencing how investors view the company’s fundamentals.</li>
<li>Neutral Sentiment: Despite the recent news flow, analysts previously remained constructive overall, with several Buy/Outperform ratings and a median price target above the current share price, suggesting some longer-term optimism remains.</li>
</ul>
<div class="lb-trans"><ul>
<li>消极情绪：包括罗森律师事务所、Faruqi &amp; Faruqi、Pomerantz、Bragar Eagel &amp; Squire、Gross 律师事务所、Robbins LLP 和 Gainey McKenna &amp; Egleston 在内的多家律师事务所宣布或推广针对 Phreesia 的集体诉讼，指控其在 2025 年 5 月 8 日至 2026 年 3 月 30 日期间可能存在证券欺诈。文章标题</li>
<li>消极情绪：这些诉讼及相关投资者警报可能增加法律费用、管理层分心，并对之前的披露产生不确定性，这可能会影响投资者对该股票的情绪。文章标题</li>
<li>中性情绪：Phreesia 最新的季度业绩表现参差不齐：收入略高于预期，但每股收益未达到共识，这可能仍在影响投资者对公司基本面的看法。</li>
<li>中性情绪：尽管近期新闻流动频繁，分析师们之前总体上仍持建设性态度，给予多个买入/跑赢大盘评级，且中位目标价高于当前股价，表明仍然存在一些长期乐观情绪。</li>
</ul>
</div><h2>About Phreesia</h2>
<div class="lb-trans"><h2>关于 Phreesia</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Phreesia, Inc NYSE: PHR is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.</p>
<div class="lb-trans"><p>Phreesia, Inc NYSE: PHR 是一家提供患者接收管理解决方案的公司，旨在简化医疗机构的前台工作流程。该公司的基于云的平台通过触摸屏自助服务机、平板电脑和移动设备数字化患者注册、预约安排、保险验证、同意文件和付款收集。通过替代纸质表格和手动流程，Phreesia 提高了数据准确性，减少了行政负担，并改善了患者体验。</p>
</div><p>Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.</p>
<div class="lb-trans"><p>Phreesia 成立于 2000 年，由 Chaim Indig 创办，总部位于马萨诸塞州伯灵顿，提供与电子病历（EMR）和实践管理系统集成的模块化软件套件。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Phreesia</li>
<li>Viking Sails to All-Time Highs—Fundamentals Signal More to Come</li>
<li>Datavalut Gains Traction: 5 Reasons to Sell Now</li>
<li>TMC Stock: Why This Pre-Revenue Miner Is Worth Watching</li>
<li>The Power Grid Is Dying—Is It Time to Buy Its Replacement?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Phreesia</li>
<li>Viking 股价创历史新高——基本面信号显示未来还有更多</li>
<li>Datavalut 获得关注：现在卖出的五个理由</li>
<li>TMC 股票：为什么这家未盈利的矿业公司值得关注</li>
<li>电网正在衰退——是时候购买其替代品了吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBIUg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=PHR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Phreesia Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Phreesia 吗？</h2>
</div><p>Before you consider Phreesia, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Phreesia 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Phreesia 并不在名单上。</p>
</div><p>While Phreesia currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Phreesia 目前在分析师中获得中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Phreesia (NYSE:PHR) Stock Rating Lowered by Barclays

Market Beat

Phreesia

巴克莱银行

瑞穗金融集团

Mizuho Financial Group, Inc.

Citizens Financial

花旗

蒙特利尔银行

Waystar

瑞杰金融

AllianceBernstein

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

CITIGROUP INC 6.250 NON CUM SER II PFD WI

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

巴克莱下调了 Phreesia（纽约证券交易所代码：PHR）的股票评级